Skip to content

A randomized controlled trial for improving blood lipids in human A randomized double-blind parallel-group study

A randomized controlled trial for improving blood lipids in human A randomized double-blind parallel-group study - A trial for improving blood lipids

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015141
Enrollment
24
Registered
2015-06-01
Start date
2014-08-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Duration: 12 weeks Test material: Krill oil 3 capsules One time / day after lunch Duration: 12 weeks Test material: Krill oil 3 capsules Three time / day Duration: 12 weeks Test material: placebo

Sponsors

ORTHOMEDICO Inc.
Lead Sponsor
Seishin-kai Medical Association Inc, Takara Medical Clinic.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: a) Healthy adults, who feel fatigue daily b) Persons who are between 30 and 59 years old

Exclusion criteria

Exclusion criteria: a)Persons who have previous medical history of malignant tumor or heart failure or myocardial infarction b)Patients being treated for at least one of following diseases atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension and other chronic disease c)Persons who take medicines, herbal medicines *Especially, to exclude persons who take anticoagulants, antithrombotic drug (acetylsalicylic acid, warfarin, etc.) d)Persons who are allergic to medicines, or products related to the test material of this trial *Especially, to exclude persons with gelatin or shellfish allergy because of including gelatin in the capsule film and shrimp essence in the placebo fragrances e)Pregnant women, lactating women, or women who want to get pregnant during the trial period f)Persons who plan an operation g)Persons who have been enrolled in the other clinical trials within last 3 months before the agreement for the participation to this trial h)Persons who are judged not suitable to participate in this trial by physician

Design outcomes

Primary

MeasureTime frame
[Blood lipids] total cholesterol HDL cholesterol LDL cholesterol Triglyceride free fatty acid

Secondary

MeasureTime frame
[Physical examination] Weight BMI Body fat percentage

Countries

Japan

Contacts

Public ContactNaoko SUZUKI

ORTHOMEDICO, Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026